| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/21/1997 | WO1997030087A1 Preparation of glycosylated antibodies |
| 08/21/1997 | WO1997030086A1 Nucleotide sequence typical for a deletion of proto-oncogene ret in exon 11 |
| 08/21/1997 | WO1997030085A1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 08/21/1997 | WO1997030084A1 Tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/21/1997 | WO1997030083A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
| 08/21/1997 | WO1997030082A2 Antifungic and antibacterial peptide |
| 08/21/1997 | WO1997030081A1 Ebna2 peptides and methods of using same |
| 08/21/1997 | WO1997030080A1 Macrocyclic peptides useful in the treatment of thrombin related disorders |
| 08/21/1997 | WO1997030079A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 08/21/1997 | WO1997030078A1 DERIVATIVES OF ANTIBIOTIC GE2270 FACTORS C2a, D2 AND E |
| 08/21/1997 | WO1997030077A1 Formyl-substituted pseudopeptides with a anti-viral action |
| 08/21/1997 | WO1997030076A1 Pseudopeptides with an anti-viral action and containing a mercaptal or thioether group |
| 08/21/1997 | WO1997030075A1 Oxime- and nitron-substituted pseudopeptides with an anti-viral action |
| 08/21/1997 | WO1997030074A1 Isolation and use of sh3 binding peptides |
| 08/21/1997 | WO1997030073A1 Serine protease inhibitors |
| 08/21/1997 | WO1997030072A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 08/21/1997 | WO1997030071A1 Triazolidin-2-yl- and 1,3-thiazan-2-yl-substituted pseudopeptides |
| 08/21/1997 | WO1997030070A1 Novel compounds |
| 08/21/1997 | WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | WO1997030064A1 Hexitol containing oligonucleotides and their use in antisense strategies |
| 08/21/1997 | WO1997029781A1 Methods and compositions for modulating an immune response |
| 08/21/1997 | WO1997029780A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | WO1997029779A2 Egf-genistein conjugates for the treatment of cancer |
| 08/21/1997 | WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | WO1997029769A1 Vaccine for b-cell malignancies |
| 08/21/1997 | WO1997029767A1 Stabilised growth hormone formulation and method of preparation thereof |
| 08/21/1997 | WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/21/1997 | WO1997029765A1 Antimicrobial peptides and methods of use |
| 08/21/1997 | WO1997029761A1 Method of producing bone-inducing agent |
| 08/21/1997 | WO1997029757A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 08/21/1997 | WO1997029751A1 Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents |
| 08/21/1997 | WO1997029738A1 Methods and compositions for treating eustachian tube dysfunction by inhalation |
| 08/21/1997 | WO1997029635A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 08/21/1997 | WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
| 08/21/1997 | WO1997007136A3 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 08/21/1997 | WO1996040937A3 Adenosine kinase polynucleotides |
| 08/21/1997 | DE19632948A1 Neue antiviral wirksame oxim- und nitronsubstituierte Pseudopeptide New antiviral effective oxime and nitro-substituted Pseudopeptides |
| 08/21/1997 | DE19605772A1 Neue antiviral wirksame formyl-substituierte Pseudopeptide New antiviral formyl-substituted Pseudopeptides |
| 08/21/1997 | DE19605769A1 Neue antiviral wirksame Pseudopeptide mit Mercaptal- oder Thioetherfunktion New antiviral effective pseudo-peptides with Mercaptal- or thioether |
| 08/21/1997 | DE19605767A1 Thiazolidin-2-yl-und 1,3-Thiazan-2-yl-substituierte Pseudopeptide Thiazolidine-2-yl and 1,3-Thiazan-2-yl-substituted pseudopeptides |
| 08/21/1997 | CA2412954A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 08/21/1997 | CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | CA2246811A1 Macrocyclic peptides useful in the treatment of thrombin related disorders |
| 08/21/1997 | CA2246712A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation |
| 08/21/1997 | CA2246578A1 Novel human myeloid terminal differentiation response gene |
| 08/21/1997 | CA2246503A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 08/21/1997 | CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | CA2246256A1 Serine protease inhibitors |
| 08/21/1997 | CA2246230A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | CA2245877A1 Hybrid proteins which form heterodimers |
| 08/21/1997 | CA2245635A1 Cardiotrophin and uses therefor |
| 08/21/1997 | CA2245518A1 Antifungic and antibacterial peptide |
| 08/21/1997 | CA2245503A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
| 08/21/1997 | CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/21/1997 | CA2243549A1 Nucleotide sequence typical for a deletion of proto-oncogene ret in exon 11 |
| 08/21/1997 | CA2242660A1 Antimicrobial peptides and methods of use |
| 08/21/1997 | CA2242067A1 Derivatives of antibiotic ge2270 factors c2a, d2 and e |
| 08/21/1997 | CA2218378A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 08/21/1997 | CA2197847A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of borna disease virus, nucleic acid fragments coding therefor and their use for diagnostic and immunization purposes |
| 08/20/1997 | EP0790313A2 Nucleic acid constructs for the cell cycle regulated expression of genes, cells comprising said constructs and their use for the preparation of medical compositions |
| 08/20/1997 | EP0790312A2 Target cell specific vectors for the insertion of genes into cells, medicament containing such vectors and their use |
| 08/20/1997 | EP0790309A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790308A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790307A1 Molecular cloning and expression of human IL-3 |
| 08/20/1997 | EP0790306A2 Tumor necrosis factor (tnf) inhibitor and use thereof |
| 08/20/1997 | EP0790305A1 Mutant human growth hormones and their uses |
| 08/20/1997 | EP0790255A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them |
| 08/20/1997 | EP0790062A1 Remedy for heart diseases |
| 08/20/1997 | EP0790061A1 Fertility agent |
| 08/20/1997 | EP0790060A1 Lipid metabolism ameliorant |
| 08/20/1997 | EP0790059A1 Means for treating auto-immune diseases and method of treatment |
| 08/20/1997 | EP0789783A1 Antigen binding peptides (abtides) from peptide libraries |
| 08/20/1997 | EP0789780A1 Methods and reagents for the identification and regulation of senescence-related genes |
| 08/20/1997 | EP0789776A1 Nucleic acid transfer system |
| 08/20/1997 | EP0789769A2 A human metalloproteinase, variants thereof and dna sequences codding therefor |
| 08/20/1997 | EP0789768A1 Respiratory syncytial virus protein g expressed on bacterial membrane |
| 08/20/1997 | EP0789767A1 Purified papillomavirus proteins |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789763A1 Icam-4 materials and methods |
| 08/20/1997 | EP0789762A1 Methods for the diagnosis of glaucoma |
| 08/20/1997 | EP0789761A1 Human scf, a splice variant thereof, its pharmaceutical use |
| 08/20/1997 | EP0789760A2 Enzymatic method for modification of recombinant polypeptides |
| 08/20/1997 | EP0789759A1 Modified factor vii |
| 08/20/1997 | EP0789716A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
| 08/20/1997 | EP0789715A1 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789711A1 IDENTIFICATION OF THE p21?WAF1 -PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF |
| 08/20/1997 | EP0789710A1 Peptides for anti-allergy treatment |
| 08/20/1997 | EP0789709A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 08/20/1997 | EP0789705A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789592A1 Ocular gene therapy |
| 08/20/1997 | EP0789591A1 Methods for identifying individuals suffering from a cellular abnormality |
| 08/20/1997 | EP0789588A1 Method for making a medicament for treating secondary immunodeficiency |
| 08/20/1997 | EP0789585A1 A storage stable water solution for infusion containing a thrombin inhibitor |
| 08/20/1997 | EP0789584A1 Application of superoxide dismutase in liposomes |
| 08/20/1997 | EP0789583A1 Methods and kits using macrophage stimulating protein |